<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">FORM 8-K</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">PURSUANT TO SECTION 13 OR 15(D)
OF</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">THE SECURITIES EXCHANGE ACT OF
1934</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center">Date of Report (Date of earliest
event reported): February 8, 2016</P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0 0 11pt; text-align: center"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><U>TELEHEALTHCARE, INC.</U></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><I>&nbsp;(Exact name
of registrant as specified in its charter)</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Commission file number: 333-201391</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; padding-right: 2.4pt; font-weight: bold; line-height: 115%; text-decoration: underline; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b><u>Wyoming</u></b></font></td>
    <td style="vertical-align: bottom; padding-right: 2.4pt; font-weight: bold; line-height: 115%; text-decoration: underline; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b><u>80-0873491</u></b></font></td>
    </tr>
<tr style="vertical-align: top">
    <td>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 2.4pt 0 0; text-align: center"><i>(State or other jurisdiction
        of</i></P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 2.4pt 0 0; text-align: center"><i>incorporation or organization)</i></P></td>
    <td style="padding-right: 2.4pt; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><i>(I.R.S. Employer Identification No.)</i></font></td>
    </tr>
<tr style="vertical-align: top">
    <td style="padding-right: 2.4pt; text-align: center; line-height: 115%">&nbsp;</td>
    <td style="padding-right: 2.4pt; text-align: center; line-height: 115%">&nbsp;</td>
    </tr>
<tr>
    <td style="vertical-align: bottom">
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 2.4pt 0 0; text-align: center"><b>1031 Calle Recodo Suite
        B, </b></P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 2.4pt 0 0; text-align: center"><b><u>San Clemente, CA </u></b></P></td>
    <td style="vertical-align: bottom; padding-right: 2.4pt; font-weight: bold; line-height: 115%; text-decoration: underline; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b><u>92673</u></b></font></td>
    </tr>
<tr style="vertical-align: top">
    <td style="padding-right: 2.4pt; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><i>(Address of principal executive offices)</i></font></td>
    <td style="padding-right: 2.4pt; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><i>(Zip Code)</i></font></td>
    </tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Registr<FONT STYLE="background-color: White">ant&rsquo;s
telephone number, including area code:</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="background-color: White"><B>(949)
423-6870</B></FONT></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 2.4pt 0 0; text-align: center"><B><U>20111 Greeley Rd, Lake
Mathews, CA&nbsp;92570</U></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt; text-align: center"><I>(Former Name or former address,
if changed since last report)</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt">[ ] Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt">[ ] Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt">[ ] Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 11pt">[ ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Forward Looking Statements</U></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Current
Report on Form 8-K, including the sections entitled &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations&rdquo; and &ldquo;Description of Business,&rdquo; contains &ldquo;forward-looking
statements&rdquo; that include information relating to future events, future financial performance, strategies, expectations, competitive
environment, regulation and availability of resources. These forward-looking statements include, without limitation: statements
regarding proposed new services; statements concerning litigation or other matters; statements concerning projections, predictions,
expectations, estimates or forecasts for our business, financial and operating results and future economic performance; statements
of management&rsquo;s goals and objectives; and other similar expressions concerning matters that are not historical facts. Words
such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;future,&rdquo; &ldquo;intends,&rdquo;
&ldquo;plans,&rdquo; &ldquo;believes&rdquo; and &ldquo;estimates,&rdquo; and similar expressions, as well as statements in future
tense, identify forward-looking statements.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Forward-looking
statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications
of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information
available at the time they are made and/or management&rsquo;s good faith belief as of that time with respect to future events,
and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed
in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited
to:</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="padding-bottom: 12pt; text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">- </font></td>
    <td style="padding-bottom: 12pt; text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">our failure to implement our business plan within the time period we originally planned to accomplish; and</font></td></tr>
</table>
<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="padding-bottom: 12pt; text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">-</font></td>
    <td style="padding-bottom: 12pt; text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">other factors discussed under the headings &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Description of Business.&rdquo;</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Forward-looking
statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume
no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more
forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking
statements.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 1.01 Entry into a Material Definitive
Agreement.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 3.02 Unregistered Sales of Equity
Securities.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B><U>CAPITAL RAISE</U></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 11,
2016, the Company partially completed a private placement offering to certain institutional and accredited investors (&ldquo;Investors&rdquo;)
pursuant to which the Company sold an aggregate of 1,000,000 shares of the Company&rsquo;s common stock resulting in gross proceeds
of $100,000 to the Company. The Company intends to use proceeds of the offering for working capital and to develop its telehealth
platform. The Company has no material relationship with any of the accredited investors participating in the private placement
offering other than in respect of the subscription agreements.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The issuance of
the shares of the Company&rsquo;s common stock to the Investors pursuant to the Subscription Agreements are intended to be exempt
from registration under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), pursuant to Section 4(2) thereof
and Rule 506 of Regulation D (&ldquo;Regulation D&rdquo;) as promulgated by the United States Securities and Exchange Commission
(&ldquo;Commission&rdquo;) under the Securities Act, as the Shares were sold to accredited investors and were not sold through
any general solicitation or advertisement. The shares sold by the Company have not been registered under the Securities Act of
1933 and may not be offered or sold in the United States absent such registration or an available exemption from registration.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A copy of the subscription agreement
is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 5.01 Changes in Control of
Registrant.&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">On February
8, 2016, Mr. Karl Hoshor resigned from the Board of Directors and all officer positions to pursue other activities. Mr. Hoshor
sold 36,000,000 shares to Mr. Derek Cahill, the incoming Chairman and CEO for $3,600. Additionally, Mr. Hoshor sold an additional
1,500,000 shares to an unaffiliated third party for $150.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in"><B><U>SECURITY
OWNERSHIP OFCERTAIN BENEFICIAL OWNERS AND MANAGEMENT PRIOR TO CHANGE IN CONTROL</U></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The following
table sets forth certain information regarding our common stock beneficially owned on February 8, 2016, prior to giving effect
to the sale, for (i) each stockholder known to be the beneficial owner of more than 5% of our outstanding common stock, (ii) each
of our executive officers and directors, and (iii) all executive officers and directors as a group. In general, a person is deemed
to be a &ldquo;beneficial owner&rdquo; of a security if that person has or shares the power to vote or direct the voting of such
security, or the power to dispose or to direct the disposition of such security. A person is also deemed to be a beneficial owner
of any securities of which the person has the right to acquire beneficial ownership within 60 days, through the exercise of a warrant
or stock option, conversion of a convertible security or otherwise. At February 8, 2016, immediately prior to the Closing, 50,291,000
shares of our common stock were outstanding. Unless otherwise noted below the address of each person identified is 1031 Calle Recodo,
Suite B, San Clemente, CA 92673.</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td style="font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%; background-color: white"><b>Amount and Nature Of Beneficial Ownership</b></font><b><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><u><sup> (1)</sup></u></font></b></td>
    <td style="font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b>Percentage of Common Stock</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; line-height: 115%">&nbsp;</td>
    <td style="text-align: center; line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%">&nbsp;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Karl Hoshor<sup>(1)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">40,000,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">79.54%</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">James Donahue<sup>(2)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">500,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">0.99</font></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Matthew Folsom<sup>3)7</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">200,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">0.40</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-bottom: 0.7pt">
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt">All officers and directors</P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt">as a group (three persons)</P></td>
    <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">40,700,000</font></td>
    <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">80.93%</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="text-align: justify; line-height: 115%">&nbsp;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(1)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Officer and director of the Company. Mr. Hoshor received 40,000,000 founder&rsquo;s shares of the Company in December 2012.</font></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(2)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Officer and director of the Company. Mr. Donahue received 500,000 shares of the Company in September 2014 for services as president.</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(3)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Director of the Company. Mr. Folsom received 200,000 founder&rsquo;s shares of the Company in September 2014 for services as vice president of sales. </font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">The following
table sets forth certain information regarding our common stock beneficially owned on February 8, 2016, immediately following the
Closing, for (i) each stockholder known to be the beneficial owner of more than 5% of our outstanding common stock, (ii) each executive
officer and director, and (iii) all executive officers and directors as a group,. In general, a person is deemed to be a &ldquo;beneficial
owner&rdquo; of a security if that person has or shares the power to vote or direct the voting of such security, or the power to
dispose or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which
the person has the right to acquire beneficial ownership within 60 days, through the exercise of a warrant or stock option, conversion
of a convertible security or otherwise. The table assumes a total of 50,291,000 shares of our common stock outstanding as of February
8, 2016. Unless otherwise noted below the address of each person identified is 1031 Calle Recodo, Suite B, San Clemente, CA 92673.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; line-height: 115%; text-decoration: underline"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">&nbsp;</font></td>
    <td style="font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%; background-color: white"><b>Amount and Nature Of Beneficial Ownership</b></font><b><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><u><sup> (1)</sup></u></font></b></td>
    <td style="font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b>Percentage of Common Stock</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; line-height: 115%">&nbsp;</td>
    <td style="text-align: center; line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%">&nbsp;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Derek Cahill<sup>(1)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">38,500,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">76.55%</font></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Karl Hoshor<sup>(2)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">2,500,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">4.97%</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">James Donahue<sup>(3)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">500,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">0.99</font></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Matthew Folsom<sup>(4)</sup></font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">200,000</font></td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">0.40</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-bottom: 0.7pt">
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt">All officers and directors</P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">as a group (three persons)</P></td>
    <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">39,200,000</font></td>
    <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">77.95%</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(1)</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Officer and director of the Company. MD Capital, which Mr. Cahill controls, received 2,500,000 shares of the Company in June 2014 for platform development. Mr. Cahill purchased 36,000,000 from Mr. Hoshor on February 8, 2016</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(2)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Former officer and director of the Company. Mr. Hoshor received 40,000,000 founder&rsquo;s shares of the Company in December 2012. Mr. Hoshor sold 37,500,000 shares on February 8, 2016</font></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(3)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Officer and director of the Company. Mr. Donahue received 500,000 shares of the Company in September 2014 for services as president.</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; letter-spacing: -0.1pt; line-height: 115%"><sup>(4)</sup></font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Director of the Company. Mr. Folsom received 200,000 founder&rsquo;s shares of the Company in September 2014 for services as vice president of sales. </font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>Item 5.02 Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B>&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in"><B><U>DIRECTORS
AND EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS</U></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">On February
8, 2016, Mr. Karl Hoshor resigned from his positions as Chief Financial Officer, Secretary and Director. Mr. Donahue resigned from
his position as President. Mr. Derek Cahill was appointed to the Board of Directors and appointed Chairman. We appointed the following
persons as our executive officers and directors.&nbsp;&nbsp;All directors serve until the next annual meeting of stockholders or
until their successors are elected and qualified.&nbsp;&nbsp;Officers are appointed by the board of directors and their terms of
office are, except to the extent governed by an employment contract, at the discretion of the board of directors.</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Name</b></font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Age</b></font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Position</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Derek Cahill</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">44</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Chief Executive Officer, President, Director and Chairman</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">James Donahue</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">71</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Chief Financial Officer, Secretary and Director</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Matt Folsom</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">43</font></td>
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Director</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">(1)</font></td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">There are no family relationships among our executive officers and directors.</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Derek Cahill</I></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Cahill has over 15 years of operations,
marketing and product development experience working for both Fortune 200 and high-growth/start-up healthcare and technology companies.
Mr. Cahill previously worked for PacifiCare Health Systems, HealthDemographics and Medibuy.com.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Working for PacifiCare Health Systems,
Mr. Cahill implemented the first electronic regulatory filings for PacifiCare&rsquo;s &amp; Secure Horizon&rsquo;s commercial and
senior product lines using a customized geographic information system (GIS) to pinpoint patient access for hospitals and medical
groups.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As VP of Product Development for HealthDemographics,
Mr. Cahill was responsible for all product development, product delivery and IT operations overseeing marketing, business development,
customer service and quality assurance teams. Mr. Cahill successfully launched three versions of HealthDemographic&rsquo;s Avenir
product line, a customized GIS system for hospitals and medical device manufacturers. Notable clients included Columbia HCA, Kaiser,
Blue Cross/Blue Shield, LensCrafters, and many others. HealthDemographics was purchased by Medirisk (Nasdaq: MDMD). As CTO/CIO
of Medibuy, Mr. Cahill developed the first online B2B healthcare supply chain product for Fortune 1000 healthcare clients. Medibuy
received over $100 million in venture funding from Kleiner-Perkins, Sequoia, Oak Investments and others. Mr. Cahill was integral
in Medibuy&rsquo;s early development, growing the company from 5 to over 400+ employees, growing the initial customer base and
developing the design and architecture for the first three versions of the online product.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>James Donahue&nbsp;</I></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Donahue has been our director and
president since September 2014. Prior to joining our company Mr. Donahue was president of MS2 Group West from 2008 to 2009 where
he establish medical strategies and systems to expand hospital emergency room operations with improved revenues and profits through
enhanced process and procedures. He served as president of ATC Healthcare from 2007 to 2008 where he was responsible for grow and
expand existing healthcare lines in travel and per diem. He served as president of TeamStaffRx from 2006 to 2007 were he was responsible
for growth, development and profitability to its parent Allied Healthcare. He served as COO for Telecom Relocation Services, Inc.
from 2004 to 2006 where he created new infrastructure for private Voice, Data and Fiber Optics. Since 2009, Mr. Donahue currently
owns and operates his own coffee cafe. Mr. Donahue obtained his BBA in Marketing and Management from Washburn University. and a
Graduate Studies in Law from Washburn University.</P>

<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Matthew Folsom</I>&nbsp; </B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Folsom has been in sales and service
for Audiometrics since 2004 covering all of Southern California and Nevada. Specializing in the hearing and balance industry, he
distributes instrumentation from multiple manufacturers and provides service to hospitals, schools, ears, nose and throat, and
audiologists. He also serves on the board for National Association of Special Equipment Distributors. He is responsible for continuing
education for service technicians around the nation who service the hearing and balance equipment sold. Mr. Folsom earned a Bachelor&rsquo;s
of Arts degree at the California State University, Chico in 1995.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Involvement in Certain Legal Proceedings</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">No executive officer or director has
been involved in the last ten years in any of the following:</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Any bankruptcy petition filed by or against any business or property of such person, or of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Being the subject of or a party to any judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state securities or commodities law or regulation, or any law or regulation respecting financial institutions or insurance companies, including but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail, fraud, wire fraud or fraud in connection with any business entity; or</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&middot;</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Being the subject of or a party to any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act, any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B><I>Executive compensation
</I></B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The following
table and related footnotes show the compensation paid to our Chief Executive Officer and to each of the other two most highly
compensated executive officers whose compensation exceeded $100,000 during the last fiscal year, and information concerning all
compensation paid for services to us in all officer capacities for our last two fiscal years.</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="background-color: white">
    <td colspan="10" style="border: #3F3F3F 2.25pt double; font-weight: bold; line-height: 115%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%"><b>SUMMARY COMPENSATION TABLE</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="border-right: #3F3F3F 2.25pt double; border-bottom: #3F3F3F 2.25pt double; border-left: #3F3F3F 2.25pt double; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Name</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">and&nbsp;</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">principal</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">position&nbsp;</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(a)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Year&nbsp;</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(b)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Salary</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)&nbsp;</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(c)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Bonus</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(d)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Stock</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Awards</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(e)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Option</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Awards</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(f)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Non-Equity</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Incentive</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Plan</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Compensation</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(g)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Nonqualified</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Deferred</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Compensation</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Earnings</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(h)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">All Other</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Compensation</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">($)</font><br>
<font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(i)</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Total</P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">($)&nbsp;<br>
        (j)</P></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-left: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double"><P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">Karl
                                         Hoshor (1)</FONT></P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">Director and CFO</FONT></P></td>
    <td style="border-right: #3F3F3F 2.25pt double; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">2015</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">$5,000</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">$5,000</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-left: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; line-height: 115%">&nbsp;</td>
    <td style="border-right: #3F3F3F 2.25pt double; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">2014</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="border-left: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double"><P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">James Donahue (2)</FONT></P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">Director and President</FONT></P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0">2015</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0">2014</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">$12,500</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">$12,500</P></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-right: #3F3F3F 2.25pt double; border-bottom: #3F3F3F 2.25pt double; border-left: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">Matthew Folsom (3)</FONT></P>
        <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt">Director</FONT></P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0">2015</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0">2014</P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">-</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double; text-align: center; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">$5,000</font></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P></td>
    <td style="border-bottom: #3F3F3F 2.25pt double; border-right: #3F3F3F 2.25pt double">
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">-</P>
        <P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">$5,000</P></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There is no formal
employment arrangement with Messrs. Cahill, Donahue, and Folsom at this time. Their compensation has not been fixed or based on
any percentage calculations. They will make all decisions determining the amount and timing of his compensation and, for the immediate
future, has elected not to receive any compensation which permits us to meet our financial obligations. Their compensation amount
may be formalized if and when the Company completes this offering and obtains any future financing beyond the offering.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(1)</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Mr. Hoshor received 40,000,000 shares of common stock of the Company as founder shares. The Company does not intend on issuing any additional shares to Mr. Hoshor for organizational services or for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $40,000.</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(2)</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Mr. Donahue received 500,000 shares of common stock of the Company for services as president. The Company does not intend on issuing any additional shares to Mr. Donahue for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $12,500.</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="line-height: 115%">&nbsp;</td>
    <td style="line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">(3)</font></td>
    <td style="text-align: justify; line-height: 115%"><font style="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 115%">Mr. Folsom received 200,000 shares of common stock of the Company for services as vice president of sales. The Company does not intend on issuing any additional shares to Mr. Folsom for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $5,000.</font></td></tr>
</table>
<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Grants of Plan-Based Awards Table</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None of our named
executive officers received any grants of stock, option awards or other plan-based awards during the period ended September 30,
2015 except as stated above. The Company has no activity with respect to these awards.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Options Exercised and Stock Vested
Table</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None of our named
executive officers exercised any stock options, and no restricted stock units, if any, held by our named executive officers vested
during the period ended September 30, 2015. The Company has no activity with respect to these awards.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Outstanding Equity Awards at Fiscal
Year-End Table</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None of our named
executive officers had any outstanding stock or option awards as of September 30, 2015 that would be compensatory to the officer.
The Company has not issued any awards to its named executive officers. The Company and its Board of Directors may grant awards
as it sees fit to its employees as well as key consultants.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><B>Compensation of Directors</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During our fiscal year ended September
30, 2015, we did not provide compensation to any of our directors for serving as our director. We currently have no formal plan
for compensating our directors for their services in their capacity as directors, although we may elect to issue stock options
to such persons from time to time. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses
incurred in connection with attendance at meetings of our board of directors. Our board of directors may award special remuneration
to any director undertaking any special services on our behalf other than services ordinarily required of a director.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Compensation Committee Interlocks
and Insider Participation</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Our board of directors is
comprised of Messrs. Cahill, Donahue, and Folsom. The entire board of directors performs the functions that would be
performed by a compensation committee. All of the directors participate in deliberations concerning the compensation paid to
executive officers.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Item 5.06 Change in Shell
Company Status.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>DESCRIPTION OF THE BUSINESS</U></B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">We have spent the last nine months
customizing our CarePanda mobile app for Apple and Android platforms. CarePanda system will launch second quarter 2016 and will
include secure text and chat communication between medical professionals, nurses, staff, vendors, pharmacists, lab contacts and
many others.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Based on initial pilot programs
with CarePanda and customer feedback, we are evolving our business model based. Telehealth will be launching a new telehealth service,
branded On.Care<SUP>TM</SUP> to target emerging opportunities in the telehealth market for specialty and private label telehealth
services. While CarePanda connects medical clinics and specialists together, On.Care<SUP>TM</SUP> connects physicians, patients
and insurers (billing) together. By launching both systems, TeleHealthCare will have a full service solution that customers have
been asking for.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">We see five key areas driving demand
for telehealth services:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Escalating Healthcare Costs</B> &ndash; Healthcare represents $3 trillion USD in costs per year (CMS.gov) in the U.S. There is an urgent and growing need to control and lower the cost of providing healthcare. <I>(https://www.cms.gov/research-statistics-data-and-systems/statis</I></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 12pt Times New Roman, Times, Serif"><I>tics-trends-and-reports/nationalhealthexpenddata/downloads/highlights.pdf)</I></FONT></P></TD></TR></TABLE>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Expanded Insured Patient
Base &ndash; </B>There has been a rapid rise in patient volumes as more people are insured with passage and implementation of the
Affordable Care Act. </FONT><BR>
<BR>
</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Aging Population &ndash;
</B>As we age we have a higher incidence of chronic diseases. The average age of the population in the U.S. is growing resulting
in an increase demand for services. It&rsquo;s estimated that 65 million baby boomers will become Medicare enrollees over the next
decade <I>(http://www.handsontelehealth.com/past-issues/74-why-is-telehealth-a-driving-force-in-healthcare)</I></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Shortage of Medical
Professionals &ndash;</B> In many cities and towns throughout the U.S. there is a shortage of medical professionals, especially
medical specialists. This is especially true for rural populations. This has created an imbalance of the available supply of practitioners
to many areas&rsquo; demand.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Regulations &ndash;
</B>Although only a few regulations have passed that allow billing and adoption of telehealth services in Medicare, Medicaid or
Commercial health insurance services, new regulations look to greatly expand telehealth adoption. </FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>A bipartisan group of US
Senators led by Brian Schatz (D-HI) has introduced new telemedicine legislation that would move to waive restrictions on Medicare
telehealth coverage that many consider antiquated or arbitrary. In addition to a coalition of six senators and three representatives,
the bill has the support of the American Medical Association, the American Telemedicine Association, and a number of other industry
groups, health systems, and tech vendors.</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>http://mobihealthnews.com/content/latest-telemedicine-bill-could-save-18b-waiving-</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>medicare-restrictions</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: 0.5in"><I>&ldquo;Telehealth
is the future of health care,&rdquo; Schatz said in a statement. &ldquo;It saves money and improves health outcomes. Our bipartisan
bill puts us on a path to transform health care delivery, making it less costly and more convenient for patients and providers.&rdquo;
</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>http://www.schatz.senate.gov/imo/media/doc/CONNECT%20for%20Health%20Act.pdf</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>The bill, called the Creating
Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, would improve access to telehealth in
three major ways. It would establish a &ldquo;bridge program&rdquo; that allows doctors participating in the Merit-based Incentive
Payment System (MIPS) to apply for demonstration waivers that would exempt them from restrictions Medicare imposes on the coverage
of telehealth. It would automatically exempt participants in alternative payment models (such as ACOs) from those restrictions.
Finally, it would expand the coverage of remote patient monitoring technologies for patients with chronic conditions.</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>Additionally, telemedicine
reimbursement options would be expanded for non-hospital sites including telestroke evaluation and management sites, Native American
health service facilities, dialysis facilities, community health centers, and rural health clinics.</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>Third Way, a centrist Washington
think tank, crunched the numbers on the first three provisions and predicts that they would save the government $1.8 billion. Although
the waiver program would increase federal spending by $1.1 billion, the other two would offset those costs.</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>http://go.avalere.com/acton/attachment/12909/f-0292/1/-/-/-/-/20160129_Telehealth%</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify"><I>20and%20RPM%20Scoring%20Memo.pdf</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B><BR>
<BR>
</B></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>PRODUCTS &amp; SERVICES:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Based on the growing market for
telehealth services, TeleHealthCare will focus its energies on building an &ldquo;end to end&rdquo; telehealth solution company
that incorporates the following services, software and devices. Many companies, including medical groups, disease management firms,
mental health providers, and others find it difficult to get all these services within one solution.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Information Technology
(IT) Services</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Secure Video and Chat
</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Platform for Electronic
Medical Records (EMR), Scheduling and Billing</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Monitoring Devices
</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Telehealth Programs
</B></FONT></TD></TR>                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Marketing Services</B></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>IT Services:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">These services offered on a &lsquo;menu&rsquo;
basis would include everything from setting up and managing a customer&rsquo;s IT network for telehealthcare; to providing training,
support, setup and configuration of the telehealth services, monitoring devices, mobile apps, an EMR platform and a billing system.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Secure Video and Chat:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">TeleHealthCare will be offering
secure, HIPAA compliant video and chat capabilities. Some customers may only want chat, others video and some both services. TeleHealthCare
can integrate video and chat into a customer&rsquo;s existing systems.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Platform for EMR, Scheduling
and Billing</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">While the majority of hospitals
have adopted EMR systems, most disease management firms, specialty medical clinics, long term care centers, skilled nursing facilities,
rehab centers and others have not yet adopted these systems. An EMR is necessary to document patient visits, manage online scheduling
of telehealth services and track billing of telehealth services.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><I>http://dashboard.healthit.gov/index.php</I></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Monitoring Devices</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">To effectively monitor and manage
patients in telehealth programs, especially patients with chronic care conditions, medical providers will need access to patient
information gathered from remote monitoring devices that can track vital signs such as ECG, heart rate, pulse oximetry, blood pressure,
temperature, weight, glucose levels, activity levels, etc. TeleHealthCare, Inc. will incorporate monitoring device management directly
into their platform to provide vital sign history and alerts on the patient&rsquo;s condition. The Company will also sell certain
devices to its customers.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Telehealth Programs</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">TeleHealthCare will develop &ldquo;packaged&rdquo;
telehealth programs that include turn-key business plans for customers to launch a telehealth program. This includes all the organization,
billing and marketing of their telehealth solution.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Telehealth Platform</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Our telehealth platform will be
branded as On.Care<SUP>TM</SUP>. The certified platform is built upon Microsoft .NET technology and is 100% SaaS based product
and hosted with a secure HIPAA compliant hosting company. On.Care<SUP>TM</SUP> will be a web-based platform that provides very
low initial investment from customers and no major upgrade charges or expensive licensing fees. On.Care<SUP>TM</SUP> provides flexibility
to access telehealth information from anywhere and on most devices &ndash; desktops, tablets and mobile devices.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On.Care<SUP>TM</SUP> is designed
and developed from physician input and is developed to reduce data entry and maximize physician time.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Features:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Electronic Health Record
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Patient Chart</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Scheduling for in-office
and online visits</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Billing for in-office
and online visits</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">ICD-10 support</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Secure video and chat
for online visits</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Secure text and chat
for in office communication and vendor communication</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">E-prescriptions</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Lab integration</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Patient device integration
(vital sign measurements, activity monitors, etc.) </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Patient portal for patients
to view physician notes, connect to online visits, manage devices and health information</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Practice management</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Organizing patient information</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Monitoring medical billing
&amp; reduce billing errors </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Improved claim accuracy</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Reporting</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Customizable Online Forms
for any medical specialty</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Transcription interface
to easily capture notes and update charts</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Meaningful use dashboard</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">HI Exchange for patient
data interopability </FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On.Care<SUP>TM</SUP> also supports
the latest billing codes for ICD-10.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Compliance:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On.Care<SUP>TM</SUP> is an ONC-ATCB
2011/2012 compliant and is certified as a complete Ambulatory EHR in accordance with the applicable certification criteria adopted
by the Secretary of Health and Human Services (HHS). The 2011/2012 criteria support the Stage 1 meaningful use measures required
to qualify eligible providers for funding under the American Recovery and Reinvestment Act (ARRA).</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On.Care<SUP>TM</SUP> is certified
with Drummond Group Inc., an Office of the National Coordinator (ONC) Authorized Testing and Certification Body (ATCB) and is available
to all physicians who want to quality for 2011 HITECH EHR Incentive payments.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The American Recovery and Reinvestment
Act (ARRA) has allocated approximately $30 billion towards the improvement of healthcare via health information technology, chronic
disease research, community health centers, and comparative effectiveness research.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Meaningful Use Guidelines:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Physicians' offices, hospitals,
and other healthcare facilities show a strong commitment to improving the quality of their services by implementing certified EHR
software. The federal government rewards many institutions that implement these solutions through EHR Incentive programs.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Simply adding electronic medical
records solutions to your practice is not enough to guarantee that you will receive payments through the Centers for Medicare &amp;
Medicaid Services Incentive Programs. You must demonstrate that you are using the software and resources meaningfully, per the
program&rsquo;s requirements.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">To attain meaningful use, your
organization must demonstrate that it is using the EHR software to meet various objectives, including:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Collect and share information
securely</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Engage with patients</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Improve efficiency while
reducing miscommunications</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Provide better patient
outcomes while empowering individuals</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The incentive program requires
that providers demonstrate that these objectives are being met over a period of stages. These stages start with showing that the
EMR software is being used to collect data, then to boost the function of the organization, and finally to improve patient outcomes.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>On.Care</B><SUP>TM</SUP><B>
Product Advantages:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Accessible anytime, anywhere</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Easy to navigate user
interface</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Multi-platform compatible
on desktop, tablet or mobile</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Template driven chart
notes to support any medical specialty</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Customizable dashboard</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Fully integrated patient
reminders</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">ePrescriptions</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Automatic transfer of
Lab results</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Dictation and transcription
interface</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Built-in Patient Portal</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Referral Portal</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Patient Education Materials
on Patient Portal</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Customized Reports</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Phone and Email Customer
Support</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Internal Security and HIPAA
</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">TeleHealthCare will follows best
practices on HIPAA security and protection for maintaining and managing healthcare information.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Marketing Services</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">To be successful in launching a
telehealth program, medical groups, clinics, long term care centers and others, will need to market their telehealth services in
their market. This may include online marketing, pay per click (PPC), search engine optimization (SEO), direct mail, billboards,
radio ads, or other media services to promote their telehealth program. The Company will offer these marketing services to its
customers to help them promote their telehealth services.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Target Market</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">TeleHealthCare is targeting medical
groups, clinics, long term care centers, skilled nursing facilities, disease management firms, rehab centers and others who will
benefit from a telehealth program. In most cases, TeleHealthCare, Inc. anticipates it will develop a private label, branded solution
for each customer that will be &ldquo;powered by TeleHealthCare&rdquo;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Out of 230,000 physician practices,
47% of physicians are in a group practices. On the patient side, 140 million Americans and 860 million people globally have at
least one chronic disease.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">It&rsquo;s estimated the Telehealth
market will be a $10 billion USD industry by the end of 2019; and also the vital sign market and wearables market will reach $10
billion USD by 2019.</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Initially the Company will target:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Internal Medicine</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Dermatology</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">ENTs </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Orthopaedics</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Podiatry</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Pediatric</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Psychiatry</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Social Workers</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 12pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Drug &amp; Rehab Centers</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The Company will also work with
disease management firms, insurance companies and even other telehealth providers. Telehealthcare.com products can be customized
and private labeled for any customer.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Target Market Demand Drivers:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">There are two key factors driving
demand for telehealth services in our target market:</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">First, reimbursement of telehealth
codes will continue to encourage physician adoption. Currently, physicians can bill up to $100 per Medicare patient per month to
monitor Medicare patients with chronic conditions using telehealth. There have also been a number of employers either through self-insurance
or working with their health insurance provider who have created carve out telehealth programs to save time and costs for their
employees / payees.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Second, consumers are driving demand.
A 2012 patient survey by Ruder Finn noted 33% of patients want their physicians to have access to remote monitoring technologies
and 40% of older patients want these technologies. It&rsquo;s also expected that home medical monitoring devices will grow from
three million patients (2013) to nineteen million patients in 2018 (Berg Insight).</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Target Market:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Telemedicine is one of the fastest growing
segments in healthcare. According to the American Telemedicine Association, there are currently about 200 telemedicine networks
with 3,500 service sites in the U.S., and nearly 1 million Americans are currently using remote cardiac heart monitors. Half of
all U.S. hospitals now use some form of telemedicine.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">A study by GlobalData indicates that the
worldwide telehealth and telemedicine market was set to grow 14% between 2011 and 2018, while the 2014 World Market for Telehealth
report</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">from HIS Technology estimates the number
of patients using such services will increase to 7 million in 2018.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">BCC Research, meanwhile, put the global
telehospital/clinic and telehome market at $19.2 billion in 2014, and it could reach $43.4 billion by 2019. Here in the U.S., Health
Affairs</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">reports that the domestic telehealth market
reached $240 million in revenue in 2013, and will grow to $1.9 billion by 2018 (an annual growth rate of 50%).</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Revenue Model:</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">It is anticipated that TeleHealthCare
will have at least three sources of revenue:</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Services: </B> The Company will
earn revenue through services described above including service fees for IT services, security services (HIPAA), training, support
and the setup and configuration of private label telehealth services</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Licensing Fees:</B> The Company
will earn licensing fees through the sale of their mobile apps including EMR system, billing system, scheduling system, online
storage, patient alerts and related software technologies.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Devices: </B>The Company will
resell<B> </B>monitoring devices for vital signs and activity tracking including ECG, heart rate, respiration rate, pulse oximetry,
blood pressure, temperature, weight, glucose and other devices. Devices will connect to mobile apps and TeleHealthCare&rsquo;s
software platform.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>COMPETITORS: </B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Teladoc (TDOC) As of January 2016,
Teladoc , &ldquo;Announced Record Annual Revenue &amp; Visits and Preliminary 2016 Outlook&rdquo;. The 2015 Preliminary Unaudited
Results shows total revenues of approximately $77 million, a 77% increase over 2014 and visits exceeding 575,000 a 92% increase
over 2014. The estimate the 2016 Outlook of total revenues of $116 to $122 million, a 55% increase over 2015 (at the midpoint)
and visits of 860,000 to 900,000, a 53% increase over 2015 (at the midpoint</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">AthenaHealth (ATHN). athenahealth,
Inc., together with its subsidiaries, provides cloud-based services and mobile applications for medical groups and health systems.
The company provides services through athenaNet, a cloud-based platform. Its services include athenaCollector, a cloud-based revenue
cycle management and practice management service; athenaClinicals for electronic health record management; athenaCommunicator,
a cloud-based patient engagement and communication service; athenaCoordinator for order transmission; and athenaCoordinator Enterprise
for care coordination, patient access, and order transmission service. The company also provides athenaCommunicator Enterprise,
a cloud-based population health management service to execute, track, and coordinate care across a provider&rsquo;s network; and
Epocrates service that include clinical information and decision support services in the areas of drug and disease information,
medical calculator and tools, clinical guidelines, clinical messaging, market research, and formulary hosting. In addition, it
offers client support, account performance monitoring, relationship management, and real-time performance monitoring services.
The company serves clients in the health care industry that include pharmaceutical companies, managed care companies, market research
firms, and others through its direct sales force and channel partners in the United States and internationally. The company was
formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. athenahealth, Inc. was founded
in 1997 and is headquartered in Watertown, Massachusetts.</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">AllScripts Healthcare Solution
(MDRX). Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting,
outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates
in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions
segment provides integrated clinical software applications, financial and information solutions, and related installation and maintenance
services, including EHR related software, financial and practice management software, related installation and training services,
and electronic claims administration services. The Population Health segment engages in performance and care logistics, and population
health strategic businesses that offer health management solutions, which enable hospitals, health systems, and accountable care
organizations to connect, transition, analyze, and coordinate care across the care community. The Managed Services segment provides
healthcare IT outsourcing solutions and remote hosting solutions, as well as professional services, such as implementation, consulting,
education, and technical support. The company serves consumers, physicians, hospitals, governments, health systems, health plans,
retail clinics, retail pharmacies, pharmacy benefit managers, and post-acute organizations. The company has a strategic partnership
with Center for Digital Innovation. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago,
Illinois.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">BiomTelemetry - Medical device
manufacturer of cardio telemetry products. Public Company (BEAT).</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Cardiac Insight - Developing advanced
body worn sensing and computing technologies for diagnostic testing in cardiology, respiratory and other complex disease states.
Private Company.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Item 9.01 Financial Statements
and Exhibits.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(a) Financial statements of business
acquired.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">None</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(b) Pro forma financial information.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">None</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(c) Shell company transactions.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">None</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(d) Exhibits.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">99.1 Form
of Subscription Agreement</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><BR CLEAR="ALL">
</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt">February 11, 2016</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt"><B>TeleHealthCare, Inc.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">By<I>:<U>_/s/ Derek Cahill</U></I><U>________________</U></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">Derek Cahill</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Exhibit Index</B></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><U>Exhibit Number&#9;</U>&#9;<U>Description</U></P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">99.1&#9;Form Subscription Agreement</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "tlltform8k02082016.htm", "description": "TELEHEALTHCARE, INC. FORM 8-K FEBRUARY 8, 2016", "secsgml_size_bytes": 141599}]
{"company-data": {"conformed-name": "TeleHealthCare, Inc.", "cik": "0001628104", "assigned-sic": "7370", "irs-number": "800873491", "state-of-incorporation": "WY", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-201391", "film-number": "161411509"}, "business-address": {"street1": "20111 GREELEY RD", "city": "LAKE MATHEWS", "state": "CA", "zip": "92570", "phone": "888 325 1064"}, "mail-address": {"street1": "20111 GREELEY RD", "city": "LAKE MATHEWS", "state": "CA", "zip": "92570"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF
THE SECURITIES EXCHANGE ACT OF
1934
Date of Report (Date of earliest
event reported): February 8, 2016
TELEHEALTHCARE, INC.
(Exact name
of registrant as specified in its charter)
Commission file number: 333-201391
Wyoming
80-0873491
(State or other jurisdiction
        of
incorporation or organization)
(I.R.S. Employer Identification No.)
1031 Calle Recodo Suite
        B,
San Clemente, CA
92673
(Address of principal executive offices)
(Zip Code)
Registr
ant's
telephone number, including area code:
(949)
423-6870
20111 Greeley Rd, Lake
Mathews, CA 92570
(Former Name or former address,
if changed since last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Forward Looking Statements
This Current
Report on Form 8-K, including the sections entitled "Risk Factors," "Management's Discussion and Analysis
of Financial Condition and Results of Operations" and "Description of Business," contains "forward-looking
statements" that include information relating to future events, future financial performance, strategies, expectations, competitive
environment, regulation and availability of resources. These forward-looking statements include, without limitation: statements
regarding proposed new services; statements concerning litigation or other matters; statements concerning projections, predictions,
expectations, estimates or forecasts for our business, financial and operating results and future economic performance; statements
of management's goals and objectives; and other similar expressions concerning matters that are not historical facts. Words
such as "may," "will," "should," "could," "would," "predicts,"
"potential," "continue," "expects," "anticipates," "future," "intends,"
"plans," "believes" and "estimates," and similar expressions, as well as statements in future
tense, identify forward-looking statements.
Forward-looking
statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications
of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information
available at the time they are made and/or management's good faith belief as of that time with respect to future events,
and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed
in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited
to:
-
our failure to implement our business plan within the time period we originally planned to accomplish; and
-
other factors discussed under the headings "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Description of Business."
Forward-looking
statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume
no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more
forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking
statements.
-
2
-
Item 1.01 Entry into a Material Definitive
Agreement.
Item 3.02 Unregistered Sales of Equity
Securities.
CAPITAL RAISE
On February 11,
2016, the Company partially completed a private placement offering to certain institutional and accredited investors ("Investors")
pursuant to which the Company sold an aggregate of 1,000,000 shares of the Company's common stock resulting in gross proceeds
of $100,000 to the Company. The Company intends to use proceeds of the offering for working capital and to develop its telehealth
platform. The Company has no material relationship with any of the accredited investors participating in the private placement
offering other than in respect of the subscription agreements.
The issuance of
the shares of the Company's common stock to the Investors pursuant to the Subscription Agreements are intended to be exempt
from registration under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Section 4(2) thereof
and Rule 506 of Regulation D ("Regulation D") as promulgated by the United States Securities and Exchange Commission
("Commission") under the Securities Act, as the Shares were sold to accredited investors and were not sold through
any general solicitation or advertisement. The shares sold by the Company have not been registered under the Securities Act of
1933 and may not be offered or sold in the United States absent such registration or an available exemption from registration.
A copy of the subscription agreement
is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
Item 5.01 Changes in Control of
Registrant.
On February
8, 2016, Mr. Karl Hoshor resigned from the Board of Directors and all officer positions to pursue other activities. Mr. Hoshor
sold 36,000,000 shares to Mr. Derek Cahill, the incoming Chairman and CEO for $3,600. Additionally, Mr. Hoshor sold an additional
1,500,000 shares to an unaffiliated third party for $150.
-
3
-
SECURITY
OWNERSHIP OFCERTAIN BENEFICIAL OWNERS AND MANAGEMENT PRIOR TO CHANGE IN CONTROL
The following
table sets forth certain information regarding our common stock beneficially owned on February 8, 2016, prior to giving effect
to the sale, for (i) each stockholder known to be the beneficial owner of more than 5% of our outstanding common stock, (ii) each
of our executive officers and directors, and (iii) all executive officers and directors as a group. In general, a person is deemed
to be a "beneficial owner" of a security if that person has or shares the power to vote or direct the voting of such
security, or the power to dispose or to direct the disposition of such security. A person is also deemed to be a beneficial owner
of any securities of which the person has the right to acquire beneficial ownership within 60 days, through the exercise of a warrant
or stock option, conversion of a convertible security or otherwise. At February 8, 2016, immediately prior to the Closing, 50,291,000
shares of our common stock were outstanding. Unless otherwise noted below the address of each person identified is 1031 Calle Recodo,
Suite B, San Clemente, CA 92673.
Amount and Nature Of Beneficial Ownership
(1)
Percentage of Common Stock
Karl Hoshor
(1)
40,000,000
79.54%
James Donahue
(2)
500,000
0.99
Matthew Folsom
3)7
200,000
0.40
All officers and directors
as a group (three persons)
40,700,000
80.93%
(1)
Officer and director of the Company. Mr. Hoshor received 40,000,000 founder's shares of the Company in December 2012.
(2)
Officer and director of the Company. Mr. Donahue received 500,000 shares of the Company in September 2014 for services as president.
(3)
Director of the Company. Mr. Folsom received 200,000 founder's shares of the Company in September 2014 for services as vice president of sales.
The following
table sets forth certain information regarding our common stock beneficially owned on February 8, 2016, immediately following the
Closing, for (i) each stockholder known to be the beneficial owner of more than 5% of our outstanding common stock, (ii) each executive
officer and director, and (iii) all executive officers and directors as a group,. In general, a person is deemed to be a "beneficial
owner" of a security if that person has or shares the power to vote or direct the voting of such security, or the power to
dispose or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which
the person has the right to acquire beneficial ownership within 60 days, through the exercise of a warrant or stock option, conversion
of a convertible security or otherwise. The table assumes a total of 50,291,000 shares of our common stock outstanding as of February
8, 2016. Unless otherwise noted below the address of each person identified is 1031 Calle Recodo, Suite B, San Clemente, CA 92673.
-
4
-
Amount and Nature Of Beneficial Ownership
(1)
Percentage of Common Stock
Derek Cahill
(1)
38,500,000
76.55%
Karl Hoshor
(2)
2,500,000
4.97%
James Donahue
(3)
500,000
0.99
Matthew Folsom
(4)
200,000
0.40
All officers and directors
as a group (three persons)
39,200,000
77.95%
(1)
Officer and director of the Company. MD Capital, which Mr. Cahill controls, received 2,500,000 shares of the Company in June 2014 for platform development. Mr. Cahill purchased 36,000,000 from Mr. Hoshor on February 8, 2016
(2)
Former officer and director of the Company. Mr. Hoshor received 40,000,000 founder's shares of the Company in December 2012. Mr. Hoshor sold 37,500,000 shares on February 8, 2016
(3)
Officer and director of the Company. Mr. Donahue received 500,000 shares of the Company in September 2014 for services as president.
(4)
Director of the Company. Mr. Folsom received 200,000 founder's shares of the Company in September 2014 for services as vice president of sales.
-
5
-
Item 5.02 Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
DIRECTORS
AND EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
On February
8, 2016, Mr. Karl Hoshor resigned from his positions as Chief Financial Officer, Secretary and Director. Mr. Donahue resigned from
his position as President. Mr. Derek Cahill was appointed to the Board of Directors and appointed Chairman. We appointed the following
persons as our executive officers and directors.  All directors serve until the next annual meeting of stockholders or
until their successors are elected and qualified.  Officers are appointed by the board of directors and their terms of
office are, except to the extent governed by an employment contract, at the discretion of the board of directors.
Name
Age
Position
Derek Cahill
44
Chief Executive Officer, President, Director and Chairman
James Donahue
71
Chief Financial Officer, Secretary and Director
Matt Folsom
43
Director
(1)
There are no family relationships among our executive officers and directors.
Derek Cahill
Mr. Cahill has over 15 years of operations,
marketing and product development experience working for both Fortune 200 and high-growth/start-up healthcare and technology companies.
Mr. Cahill previously worked for PacifiCare Health Systems, HealthDemographics and Medibuy.com.
Working for PacifiCare Health Systems,
Mr. Cahill implemented the first electronic regulatory filings for PacifiCare's & Secure Horizon's commercial and
senior product lines using a customized geographic information system (GIS) to pinpoint patient access for hospitals and medical
groups.
As VP of Product Development for HealthDemographics,
Mr. Cahill was responsible for all product development, product delivery and IT operations overseeing marketing, business development,
customer service and quality assurance teams. Mr. Cahill successfully launched three versions of HealthDemographic's Avenir
product line, a customized GIS system for hospitals and medical device manufacturers. Notable clients included Columbia HCA, Kaiser,
Blue Cross/Blue Shield, LensCrafters, and many others. HealthDemographics was purchased by Medirisk (Nasdaq: MDMD). As CTO/CIO
of Medibuy, Mr. Cahill developed the first online B2B healthcare supply chain product for Fortune 1000 healthcare clients. Medibuy
received over $100 million in venture funding from Kleiner-Perkins, Sequoia, Oak Investments and others. Mr. Cahill was integral
in Medibuy's early development, growing the company from 5 to over 400+ employees, growing the initial customer base and
developing the design and architecture for the first three versions of the online product.
-
6
-
James Donahue
Mr. Donahue has been our director and
president since September 2014. Prior to joining our company Mr. Donahue was president of MS2 Group West from 2008 to 2009 where
he establish medical strategies and systems to expand hospital emergency room operations with improved revenues and profits through
enhanced process and procedures. He served as president of ATC Healthcare from 2007 to 2008 where he was responsible for grow and
expand existing healthcare lines in travel and per diem. He served as president of TeamStaffRx from 2006 to 2007 were he was responsible
for growth, development and profitability to its parent Allied Healthcare. He served as COO for Telecom Relocation Services, Inc.
from 2004 to 2006 where he created new infrastructure for private Voice, Data and Fiber Optics. Since 2009, Mr. Donahue currently
owns and operates his own coffee cafe. Mr. Donahue obtained his BBA in Marketing and Management from Washburn University. and a
Graduate Studies in Law from Washburn University.
Matthew Folsom
Mr. Folsom has been in sales and service
for Audiometrics since 2004 covering all of Southern California and Nevada. Specializing in the hearing and balance industry, he
distributes instrumentation from multiple manufacturers and provides service to hospitals, schools, ears, nose and throat, and
audiologists. He also serves on the board for National Association of Special Equipment Distributors. He is responsible for continuing
education for service technicians around the nation who service the hearing and balance equipment sold. Mr. Folsom earned a Bachelor's
of Arts degree at the California State University, Chico in 1995.
Involvement in Certain Legal Proceedings
No executive officer or director has
been involved in the last ten years in any of the following:
·
Any bankruptcy petition filed by or against any business or property of such person, or of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
·
Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
·
Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;
·
Being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
-
7
-
·
Being the subject of or a party to any judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state securities or commodities law or regulation, or any law or regulation respecting financial institutions or insurance companies, including but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail, fraud, wire fraud or fraud in connection with any business entity; or
·
Being the subject of or a party to any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act, any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.
Executive compensation
The following
table and related footnotes show the compensation paid to our Chief Executive Officer and to each of the other two most highly
compensated executive officers whose compensation exceeded $100,000 during the last fiscal year, and information concerning all
compensation paid for services to us in all officer capacities for our last two fiscal years.
SUMMARY COMPENSATION TABLE
Name
and
principal
position
(a)
Year
(b)
Salary
($)
(c)
Bonus
($)
(d)
Stock
Awards
($)
(e)
Option
Awards
($)
(f)
Non-Equity
Incentive
Plan
Compensation
($)
(g)
Nonqualified
Deferred
Compensation
Earnings
($)
(h)
All Other
Compensation
($)
(i)
Total
($)
(j)
Karl
                                         Hoshor (1)
Director and CFO
2015
$5,000
-
-
-
-
-
-
$5,000
2014
-
-
-
-
-
-
-
-
James Donahue (2)
Director and President
2015
2014
-
-
-
-
-
$12,500
-
-
-
-
-
-
-
-
-
$12,500
Matthew Folsom (3)
Director
2015
2014
-
-
$5,000
-
-
-
-
-
-
-
-
-
$5,000
-
8
-
There is no formal
employment arrangement with Messrs. Cahill, Donahue, and Folsom at this time. Their compensation has not been fixed or based on
any percentage calculations. They will make all decisions determining the amount and timing of his compensation and, for the immediate
future, has elected not to receive any compensation which permits us to meet our financial obligations. Their compensation amount
may be formalized if and when the Company completes this offering and obtains any future financing beyond the offering.
(1)
Mr. Hoshor received 40,000,000 shares of common stock of the Company as founder shares. The Company does not intend on issuing any additional shares to Mr. Hoshor for organizational services or for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $40,000.
(2)
Mr. Donahue received 500,000 shares of common stock of the Company for services as president. The Company does not intend on issuing any additional shares to Mr. Donahue for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $12,500.
(3)
Mr. Folsom received 200,000 shares of common stock of the Company for services as vice president of sales. The Company does not intend on issuing any additional shares to Mr. Folsom for his activities as an officer or director for the foreseeable future. The Company has valued these shares at $5,000.
Grants of Plan-Based Awards Table
None of our named
executive officers received any grants of stock, option awards or other plan-based awards during the period ended September 30,
2015 except as stated above. The Company has no activity with respect to these awards.
Options Exercised and Stock Vested
Table
None of our named
executive officers exercised any stock options, and no restricted stock units, if any, held by our named executive officers vested
during the period ended September 30, 2015. The Company has no activity with respect to these awards.
Outstanding Equity Awards at Fiscal
Year-End Table
None of our named
executive officers had any outstanding stock or option awards as of September 30, 2015 that would be compensatory to the officer.
The Company has not issued any awards to its named executive officers. The Company and its Board of Directors may grant awards
as it sees fit to its employees as well as key consultants.
-
9
-
Compensation of Directors
During our fiscal year ended September
30, 2015, we did not provide compensation to any of our directors for serving as our director. We currently have no formal plan
for compensating our directors for their services in their capacity as directors, although we may elect to issue stock options
to such persons from time to time. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses
incurred in connection with attendance at meetings of our board of directors. Our board of directors may award special remuneration
to any director undertaking any special services on our behalf other than services ordinarily required of a director.
Compensation Committee Interlocks
and Insider Participation
Our board of directors is
comprised of Messrs. Cahill, Donahue, and Folsom. The entire board of directors performs the functions that would be
performed by a compensation committee. All of the directors participate in deliberations concerning the compensation paid to
executive officers.
-
10
-
Item 5.06 Change in Shell
Company Status.
DESCRIPTION OF THE BUSINESS
We have spent the last nine months
customizing our CarePanda mobile app for Apple and Android platforms. CarePanda system will launch second quarter 2016 and will
include secure text and chat communication between medical professionals, nurses, staff, vendors, pharmacists, lab contacts and
many others.
Based on initial pilot programs
with CarePanda and customer feedback, we are evolving our business model based. Telehealth will be launching a new telehealth service,
branded On.Care
TM
to target emerging opportunities in the telehealth market for specialty and private label telehealth
services. While CarePanda connects medical clinics and specialists together, On.Care
TM
connects physicians, patients
and insurers (billing) together. By launching both systems, TeleHealthCare will have a full service solution that customers have
been asking for.
We see five key areas driving demand
for telehealth services:
·
Escalating Healthcare Costs
– Healthcare represents $3 trillion USD in costs per year (CMS.gov) in the U.S. There is an urgent and growing need to control and lower the cost of providing healthcare.
(https://www.cms.gov/research-statistics-data-and-systems/statis
tics-trends-and-reports/nationalhealthexpenddata/downloads/highlights.pdf)
·
Expanded Insured Patient
Base –
There has been a rapid rise in patient volumes as more people are insured with passage and implementation of the
Affordable Care Act.
·
Aging Population –
As we age we have a higher incidence of chronic diseases. The average age of the population in the U.S. is growing resulting
in an increase demand for services. It's estimated that 65 million baby boomers will become Medicare enrollees over the next
decade
(http://www.handsontelehealth.com/past-issues/74-why-is-telehealth-a-driving-force-in-healthcare)
·
Shortage of Medical
Professionals –
In many cities and towns throughout the U.S. there is a shortage of medical professionals, especially
medical specialists. This is especially true for rural populations. This has created an imbalance of the available supply of practitioners
to many areas' demand.
-
11
-
·
Regulations –
Although only a few regulations have passed that allow billing and adoption of telehealth services in Medicare, Medicaid or
Commercial health insurance services, new regulations look to greatly expand telehealth adoption.
A bipartisan group of US
Senators led by Brian Schatz (D-HI) has introduced new telemedicine legislation that would move to waive restrictions on Medicare
telehealth coverage that many consider antiquated or arbitrary. In addition to a coalition of six senators and three representatives,
the bill has the support of the American Medical Association, the American Telemedicine Association, and a number of other industry
groups, health systems, and tech vendors.
http://mobihealthnews.com/content/latest-telemedicine-bill-could-save-18b-waiving-
medicare-restrictions
"Telehealth
is the future of health care," Schatz said in a statement. "It saves money and improves health outcomes. Our bipartisan
bill puts us on a path to transform health care delivery, making it less costly and more convenient for patients and providers."
http://www.schatz.senate.gov/imo/media/doc/CONNECT%20for%20Health%20Act.pdf
The bill, called the Creating
Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, would improve access to telehealth in
three major ways. It would establish a "bridge program" that allows doctors participating in the Merit-based Incentive
Payment System (MIPS) to apply for demonstration waivers that would exempt them from restrictions Medicare imposes on the coverage
of telehealth. It would automatically exempt participants in alternative payment models (such as ACOs) from those restrictions.
Finally, it would expand the coverage of remote patient monitoring technologies for patients with chronic conditions.
Additionally, telemedicine
reimbursement options would be expanded for non-hospital sites including telestroke evaluation and management sites, Native American
health service facilities, dialysis facilities, community health centers, and rural health clinics.
Third Way, a centrist Washington
think tank, crunched the numbers on the first three provisions and predicts that they would save the government $1.8 billion. Although
the waiver program would increase federal spending by $1.1 billion, the other two would offset those costs.
http://go.avalere.com/acton/attachment/12909/f-0292/1/-/-/-/-/20160129_Telehealth%
20and%20RPM%20Scoring%20Memo.pdf
-
12
-
PRODUCTS & SERVICES:
Based on the growing market for
telehealth services, TeleHealthCare will focus its energies on building an "end to end" telehealth solution company
that incorporates the following services, software and devices. Many companies, including medical groups, disease management firms,
mental health providers, and others find it difficult to get all these services within one solution.
·
Information Technology
(IT) Services
·
Secure Video and Chat
·
Platform for Electronic
Medical Records (EMR), Scheduling and Billing
·
Monitoring Devices
·
Telehealth Programs
·
Marketing Services
IT Services:
These services offered on a 'menu'
basis would include everything from setting up and managing a customer's IT network for telehealthcare; to providing training,
support, setup and configuration of the telehealth services, monitoring devices, mobile apps, an EMR platform and a billing system.
Secure Video and Chat:
TeleHealthCare will be offering
secure, HIPAA compliant video and chat capabilities. Some customers may only want chat, others video and some both services. TeleHealthCare
can integrate video and chat into a customer's existing systems.
Platform for EMR, Scheduling
and Billing
While the majority of hospitals
have adopted EMR systems, most disease management firms, specialty medical clinics, long term care centers, skilled nursing facilities,
rehab centers and others have not yet adopted these systems. An EMR is necessary to document patient visits, manage online scheduling
of telehealth services and track billing of telehealth services.
http://dashboard.healthit.gov/index.php
Monitoring Devices
To effectively monitor and manage
patients in telehealth programs, especially patients with chronic care conditions, medical providers will need access to patient
information gathered from remote monitoring devices that can track vital signs such as ECG, heart rate, pulse oximetry, blood pressure,
temperature, weight, glucose levels, activity levels, etc. TeleHealthCare, Inc. will incorporate monitoring device management directly
into their platform to provide vital sign history and alerts on the patient's condition. The Company will also sell certain
devices to its customers.
-
13
-
Telehealth Programs
TeleHealthCare will develop "packaged"
telehealth programs that include turn-key business plans for customers to launch a telehealth program. This includes all the organization,
billing and marketing of their telehealth solution.
Telehealth Platform
Our telehealth platform will be
branded as On.Care
TM
. The certified platform is built upon Microsoft .NET technology and is 100% SaaS based product
and hosted with a secure HIPAA compliant hosting company. On.Care
TM
will be a web-based platform that provides very
low initial investment from customers and no major upgrade charges or expensive licensing fees. On.Care
TM
provides flexibility
to access telehealth information from anywhere and on most devices – desktops, tablets and mobile devices.
On.Care
TM
is designed
and developed from physician input and is developed to reduce data entry and maximize physician time.
Features:
·
Electronic Health Record
·
Patient Chart
·
Scheduling for in-office
and online visits
·
Billing for in-office
and online visits
·
ICD-10 support
·
Secure video and chat
for online visits
·
Secure text and chat
for in office communication and vendor communication
·
E-prescriptions
·
Lab integration
·
Patient device integration
(vital sign measurements, activity monitors, etc.)
·
Patient portal for patients
to view physician notes, connect to online visits, manage devices and health information
·
Practice management
·
Organizing patient information
·
Monitoring medical billing
& reduce billing errors
·
Improved claim accuracy
·
Reporting
·
Customizable Online Forms
for any medical specialty
·
Transcription interface
to easily capture notes and update charts
·
Meaningful use dashboard
·
HI Exchange for patient
data interopability
On.Care
TM
also supports
the latest billing codes for ICD-10.
-
14
-
Compliance:
On.Care
TM
is an ONC-ATCB
2011/2012 compliant and is certified as a complete Ambulatory EHR in accordance with the applicable certification criteria adopted
by the Secretary of Health and Human Services (HHS). The 2011/2012 criteria support the Stage 1 meaningful use measures required
to qualify eligible providers for funding under the American Recovery and Reinvestment Act (ARRA).
On.Care
TM
is certified
with Drummond Group Inc., an Office of the National Coordinator (ONC) Authorized Testing and Certification Body (ATCB) and is available
to all physicians who want to quality for 2011 HITECH EHR Incentive payments.
The American Recovery and Reinvestment
Act (ARRA) has allocated approximately $30 billion towards the improvement of healthcare via health information technology, chronic
disease research, community health centers, and comparative effectiveness research.
Meaningful Use Guidelines:
Physicians' offices, hospitals,
and other healthcare facilities show a strong commitment to improving the quality of their services by implementing certified EHR
software. The federal government rewards many institutions that implement these solutions through EHR Incentive programs.
Simply adding electronic medical
records solutions to your practice is not enough to guarantee that you will receive payments through the Centers for Medicare &
Medicaid Services Incentive Programs. You must demonstrate that you are using the software and resources meaningfully, per the
program's requirements.
To attain meaningful use, your
organization must demonstrate that it is using the EHR software to meet various objectives, including:
·
Collect and share information
securely
·
Engage with patients
·
Improve efficiency while
reducing miscommunications
·
Provide better patient
outcomes while empowering individuals
The incentive program requires
that providers demonstrate that these objectives are being met over a period of stages. These stages start with showing that the
EMR software is being used to collect data, then to boost the function of the organization, and finally to improve patient outcomes.
-
15
-
On.Care
TM
Product Advantages:
·
Accessible anytime, anywhere
·
Easy to navigate user
interface
·
Multi-platform compatible
on desktop, tablet or mobile
·
Template driven chart
notes to support any medical specialty
·
Customizable dashboard
·
Fully integrated patient
reminders
·
ePrescriptions
·
Automatic transfer of
Lab results
·
Dictation and transcription
interface
·
Built-in Patient Portal
·
Referral Portal
·
Patient Education Materials
on Patient Portal
·
Customized Reports
·
Phone and Email Customer
Support
Internal Security and HIPAA
TeleHealthCare will follows best
practices on HIPAA security and protection for maintaining and managing healthcare information.
Marketing Services
To be successful in launching a
telehealth program, medical groups, clinics, long term care centers and others, will need to market their telehealth services in
their market. This may include online marketing, pay per click (PPC), search engine optimization (SEO), direct mail, billboards,
radio ads, or other media services to promote their telehealth program. The Company will offer these marketing services to its
customers to help them promote their telehealth services.
Target Market
TeleHealthCare is targeting medical
groups, clinics, long term care centers, skilled nursing facilities, disease management firms, rehab centers and others who will
benefit from a telehealth program. In most cases, TeleHealthCare, Inc. anticipates it will develop a private label, branded solution
for each customer that will be "powered by TeleHealthCare"
Out of 230,000 physician practices,
47% of physicians are in a group practices. On the patient side, 140 million Americans and 860 million people globally have at
least one chronic disease.
It's estimated the Telehealth
market will be a $10 billion USD industry by the end of 2019; and also the vital sign market and wearables market will reach $10
billion USD by 2019.
-
16
-
Initially the Company will target:
·
Internal Medicine
·
Dermatology
·
ENTs
·
Orthopaedics
·
Podiatry
·
Pediatric
·
Psychiatry
·
Social Workers
·
Drug & Rehab Centers
The Company will also work with
disease management firms, insurance companies and even other telehealth providers. Telehealthcare.com products can be customized
and private labeled for any customer.
Target Market Demand Drivers:
There are two key factors driving
demand for telehealth services in our target market:
First, reimbursement of telehealth
codes will continue to encourage physician adoption. Currently, physicians can bill up to $100 per Medicare patient per month to
monitor Medicare patients with chronic conditions using telehealth. There have also been a number of employers either through self-insurance
or working with their health insurance provider who have created carve out telehealth programs to save time and costs for their
employees / payees.
Second, consumers are driving demand.
A 2012 patient survey by Ruder Finn noted 33% of patients want their physicians to have access to remote monitoring technologies
and 40% of older patients want these technologies. It's also expected that home medical monitoring devices will grow from
three million patients (2013) to nineteen million patients in 2018 (Berg Insight).
Target Market:
Telemedicine is one of the fastest growing
segments in healthcare. According to the American Telemedicine Association, there are currently about 200 telemedicine networks
with 3,500 service sites in the U.S., and nearly 1 million Americans are currently using remote cardiac heart monitors. Half of
all U.S. hospitals now use some form of telemedicine.
A study by GlobalData indicates that the
worldwide telehealth and telemedicine market was set to grow 14% between 2011 and 2018, while the 2014 World Market for Telehealth
report
from HIS Technology estimates the number
of patients using such services will increase to 7 million in 2018.
-
17
-
BCC Research, meanwhile, put the global
telehospital/clinic and telehome market at $19.2 billion in 2014, and it could reach $43.4 billion by 2019. Here in the U.S., Health
Affairs
reports that the domestic telehealth market
reached $240 million in revenue in 2013, and will grow to $1.9 billion by 2018 (an annual growth rate of 50%).
Revenue Model:
It is anticipated that TeleHealthCare
will have at least three sources of revenue:
Services:
The Company will
earn revenue through services described above including service fees for IT services, security services (HIPAA), training, support
and the setup and configuration of private label telehealth services
Licensing Fees:
The Company
will earn licensing fees through the sale of their mobile apps including EMR system, billing system, scheduling system, online
storage, patient alerts and related software technologies.
Devices:
The Company will
resell
monitoring devices for vital signs and activity tracking including ECG, heart rate, respiration rate, pulse oximetry,
blood pressure, temperature, weight, glucose and other devices. Devices will connect to mobile apps and TeleHealthCare's
software platform.
COMPETITORS:
Teladoc (TDOC) As of January 2016,
Teladoc , "Announced Record Annual Revenue & Visits and Preliminary 2016 Outlook". The 2015 Preliminary Unaudited
Results shows total revenues of approximately $77 million, a 77% increase over 2014 and visits exceeding 575,000 a 92% increase
over 2014. The estimate the 2016 Outlook of total revenues of $116 to $122 million, a 55% increase over 2015 (at the midpoint)
and visits of 860,000 to 900,000, a 53% increase over 2015 (at the midpoint
AthenaHealth (ATHN). athenahealth,
Inc., together with its subsidiaries, provides cloud-based services and mobile applications for medical groups and health systems.
The company provides services through athenaNet, a cloud-based platform. Its services include athenaCollector, a cloud-based revenue
cycle management and practice management service; athenaClinicals for electronic health record management; athenaCommunicator,
a cloud-based patient engagement and communication service; athenaCoordinator for order transmission; and athenaCoordinator Enterprise
for care coordination, patient access, and order transmission service. The company also provides athenaCommunicator Enterprise,
a cloud-based population health management service to execute, track, and coordinate care across a provider's network; and
Epocrates service that include clinical information and decision support services in the areas of drug and disease information,
medical calculator and tools, clinical guidelines, clinical messaging, market research, and formulary hosting. In addition, it
offers client support, account performance monitoring, relationship management, and real-time performance monitoring services.
The company serves clients in the health care industry that include pharmaceutical companies, managed care companies, market research
firms, and others through its direct sales force and channel partners in the United States and internationally. The company was
formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. athenahealth, Inc. was founded
in 1997 and is headquartered in Watertown, Massachusetts.
-
18
-
AllScripts Healthcare Solution
(MDRX). Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting,
outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates
in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions
segment provides integrated clinical software applications, financial and information solutions, and related installation and maintenance
services, including EHR related software, financial and practice management software, related installation and training services,
and electronic claims administration services. The Population Health segment engages in performance and care logistics, and population
health strategic businesses that offer health management solutions, which enable hospitals, health systems, and accountable care
organizations to connect, transition, analyze, and coordinate care across the care community. The Managed Services segment provides
healthcare IT outsourcing solutions and remote hosting solutions, as well as professional services, such as implementation, consulting,
education, and technical support. The company serves consumers, physicians, hospitals, governments, health systems, health plans,
retail clinics, retail pharmacies, pharmacy benefit managers, and post-acute organizations. The company has a strategic partnership
with Center for Digital Innovation. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago,
Illinois.
BiomTelemetry - Medical device
manufacturer of cardio telemetry products. Public Company (BEAT).
Cardiac Insight - Developing advanced
body worn sensing and computing technologies for diagnostic testing in cardiology, respiratory and other complex disease states.
Private Company.
Item 9.01 Financial Statements
and Exhibits.
(a) Financial statements of business
acquired.
None
(b) Pro forma financial information.
None
(c) Shell company transactions.
None
(d) Exhibits.
99.1 Form
of Subscription Agreement
-
19
-
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
February 11, 2016
TeleHealthCare, Inc.
By
:
_/s/ Derek Cahill
________________
Derek Cahill
Chief Executive Officer
-
20
-
Exhibit Index
Exhibit Number
Description
99.1	Form Subscription Agreement
-
21
-